VANDA PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $504.9M | $52.1M |
| FY2022 | — | $527.2M | $135.0M |
| FY2023 | — | $544.9M | $135.8M |
| FY2024 | — | $538.5M | $102.3M |
| FY2025 | — | $327.2M | $84.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $504.9M | $52.1M |
| FY2022 | — | $527.2M | $135.0M |
| FY2023 | — | $544.9M | $135.8M |
| FY2024 | — | $538.5M | $102.3M |
| FY2025 | — | $327.2M | $84.9M |